Obesity, M&A, Biotech Resurgence: A 2026 Guide to Health Stocks
The health-care corner of the US equity market has traditionally been viewed as defensive, thanks to steady growth…
GraphiteRx and Mark Cuban Cost Plus Drugs Deepen Partnership to Advance Availability of Lower-Cost Medications
Powering the Cost Plus Marketplace for Businesses Through Transparency, Innovation and Trust NASHVILLE, Tenn., December 4, 2025 (Newswire.com)…
Health-Care Earnings Top S&P 500 on Strong Drug, Hospital Demand
The largest American public health-care companies outperformed other industries in the third quarter, as higher new and specialty…
Freya Pharma Solutions Rebrands as Arletta Pharma
New name reflects company’s transformation as it advances toward the final phase of Lybrido™’s clinical development The Arletta…
European Obesity Stocks Join Healthcare Rally as AI Trade Ebbs
European weight-loss drug developers have staged something of a comeback this week, as investors rotate into healthcare from…
Pfizer Sweetens Its Offer for Metsera in Bidding War Against Novo
Pfizer Inc. agreed to buy Metsera Inc. for up to $10 billion, prevailing over Novo Nordisk A/S in…
Why US Drug Prices Are So High. Can Trump Really Cut Them?
Americans spend more on prescription drugs than anyone else in the world. It’s true that they take a…
Pfizer Races to Salvage Obesity Drugmaker Deal After Novo’s Bid – Bloomberg.com
Pfizer Races to Salvage Obesity Drugmaker Deal After Novo’s Bid Bloomberg.comNovo Nordisk’s Metsera bid shows how far it’ll go…
This Open Enrollment Season Employers Are Passing More Costs on to Workers
Americans embarking on the annual task of sifting through the health plans offered by their employers to find…
Cigna Will End Drug Rebates in Many Private Health Plans in 2027
Cigna Group will eliminate prescription drug rebates in many of its commercial health plans in 2027, upending an…
Can Huntington’s Disease Be Cured? A New Breakthrough Gene Therapy Offers Hope
Hi, this is Naomi in Berlin. Today I’m looking west to Scotland, where the possibility of a treatment…
New ALS Research Backs Trailblazer’s Focus on Immune System
Hi, it’s Jason in Melbourne. A study in Nature last week shows the immune system itself may be…